ELDON BIOLOGICALS A/S: Financial statements 2013
CVR: 26747007
Source: annual report 2013, Danish Business Authority
01/07/2012 – 30/06/2013
ELDON BIOLOGICALS A/S (CVR 26747007) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 4,092,292 and a net result of DKK 948,720. Equity in the 2013 report amounted to DKK -2,250,275.
- Gross Profit
- DKK 4,092,292
- Profit/Loss
- DKK 948,720
- Equity
- DKK -2,250,275
- Total Assets
- DKK 4,041,325
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
As of April 26, 2013, V & CO STATSAUTORISERET REVISIONSANPARTSSELSKAB has been appointed auditor of ELDON BIOLOGICALS A/S.
As of April 26, 2013, Per Sleimann Petersen has stepped down as auditor of ELDON BIOLOGICALS A/S.
About ELDON BIOLOGICALS A/S
ELDON BIOLOGICALS A/S is a Danish company of the type Aktieselskab based in Gentofte, founded in 2002. The company is registered under the industry Fremstilling af andre kemiske produkter i.a.n.. The management consists of Kasper Juul Hedegaard. The board consists of Michael Lützhøft Hansen (chair), Cara Beth Seiderman and Kasper Juul Hedegaard. The company is owned by MEDI-TRADE ApS and HOLDINGSELSKABET MLH ApS. The company has 9 employees (2018). In 2025, the company reported a gross profit of DKK 13,635,058 and a net result of DKK 3,900,353 compared with DKK 6,673,643 the year before. Equity in the 2025 report amounted to DKK 42,055,949.